首页> 外文OA文献 >What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial.
【2h】

What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial.

机译:推动初级保健中慢性肾病(CKD)质量改善的因素:慢性肾病质量改善(QICKD)试验的过程评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES: This study is a process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) study, comparing audit-based education (ABE) and sending clinical guidelines and prompts (G&P) with usual practice, in improving systolic blood pressure control in primary care. This evaluation aimed to explore how far clinical staff in participating practices were aware of the intervention, and why change in practice might have taken place. SETTING: 4 primary care practices in England: 2 received ABE, and 2 G&P. We purposively selected 1 northern/southern/city and rural practice from each study arm (from a larger pool of 132 practices as part of the QICKD trial). PARTICIPANTS: The 4 study practices were purposively sampled, and focus groups conducted with staff from each. All staff members were invited to attend. INTERVENTIONS: Focus groups in each of 4 practices, at the mid-study point and at the end. 4 additional trial practices not originally selected for in-depth process evaluation took part in end of trial focus groups, to a total of 12 focus groups. These were recorded, transcribed and analysed using the framework approach. RESULTS: 5 themes emerged: (1) involvement in the study made participants more positive about the CKD register; (2) clinicians did not always explain to patients that they had CKD; (3) while practitioners improved their monitoring of CKD, many were sceptical that it improved care and were more motivated by pay-for-performance measures; (4) the impact of study interventions on practice was generally positive, particularly the interaction with specialists, included in ABE; (5) the study stimulated ideas for future clinical practice. CONCLUSIONS: Improving quality in CKD is complex. Lack of awareness of clinical guidelines and scepticism about their validity are barriers to change. While pay-for-performance incentives are the main driver for change, quality improvement interventions can have a complementary influence.
机译:目的:本研究是对慢性肾脏病质量改善(QICKD)研究的过程评估,将基于审计的教育(ABE)与常规方法进行临床指南和提示(G&P)进行比较,以改善原发性收缩压控制关心。这项评估旨在探讨参与实践的临床人员对干预的了解程度,以及实践发生改变的原因。地点:英格兰的4种初级保健实践:2例接受ABE和2例G&P。我们有目的地从每个研究部门中选择1个北部/南部/城市和乡村实践(作为QICKD试验的一部分,从132种实践中选择)。参与者:有目的地对这4种研究方法进行了抽样,并与每个研究人员进行了焦点小组讨论。邀请所有工作人员参加。干预措施:在研究的中期和末期,在4种实践中的每一种中都进行焦点小组讨论。最初没有选择进行深入过程评估的4种其他试验方法参加了试验焦点小组讨论,共有12个焦点小组参加。使用框架方法记录,转录和分析这些内容。结果:出现了5个主题:(1)参与研究使参与者对CKD登记册更加肯定; (2)临床医生并不总是向患者解释他们患有CKD; (3)虽然从业者改善了对CKD的监测,但许多人对它改善了护理表示怀疑,并更愿意为绩效绩效付费。 (4)研究干预措施对实践的影响总体上是积极的,特别是与ABE中包括的与专家的互动; (5)该研究激发了未来临床实践的思路。结论:提高CKD的质量很复杂。缺乏对临床指南的了解以及对其有效性的怀疑是改变的障碍。绩效薪酬激励是变革的主要驱动力,而质量改进措施则可以产生补充影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号